Deep depression weakens into land depression

Dhaka, Sept. 29 -- The deep depression over the North Andaman Sea and adjoining areas has crossed the Myanmar coast and weakened into a land depression, according to the Bangladesh Meteorological Depa... Read More

Schoolgirl found hanging in Pirojpur home

Pirojpur, Sept. 29 -- Police recovered the hanging body of a schoolgirl from her house in Bhandaria upazila of Pirojpur on Tuesday. The deceased was identified as Mahira Akter, a Class-X student of B... Read More

BSEB School Librarian Eligibility Test 2026: Registration begins on October 1, check exam pattern and eligibility

India, Sept. 29 -- Bihar School Examination Board has announced the registration date for the BSEB School Librarian Eligibility Test 2026. The registration process will begin on October 1 and will end... Read More

BSEB School Librarian Eligibility Test 2026: Registration begins on October 1, check exam pattern and eligibility

India, Sept. 29 -- Bihar School Examination Board has announced the registration date for the BSEB School Librarian Eligibility Test 2026. The registration process will begin on October 1 and will end... Read More

Britain reopens refugee routes for Afghans, Palestinians as immigration and integration battle intensifies

London, Sept. 29 -- Britain is reopening its refugee resettlement system to new referrals, with Home Secretary Shabana Mahmood promising "safe and legal routes" for vulnerable refugees - including Afg... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Sept. 29 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Sept. 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Sept. 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Sept. 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, Sept. 29 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More

• ««
• «
• 5610
• 5611
• 5612
• 5613
• 5614
• 5615
• 5616
• 5617
• 5618
• 5619
• »
• »»